Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Phone858-459-7800
Debt
Current Ratio4.10
Quick Ratio4.10
Price-To-Earnings
Sales & Book Value
Annual Sales$150,000.00
Price / Sales154.79
Price / Cash FlowN/A
Price / Book3.61
Profitability
Net Income$-5,670,000.00
Net MarginsN/A
Return on Assets-81.76%
Miscellaneous
Employees6
OptionableNot Optionable
Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions
What is Aethlon Medical's stock symbol?
Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."
How were Aethlon Medical's earnings last quarter?
Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings results on Tuesday, November, 6th. The medical equipment provider reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.01. View Aethlon Medical's Earnings History.
When is Aethlon Medical's next earnings date?
What price target have analysts set for AEMD?
1 Wall Street analysts have issued 1 year price objectives for Aethlon Medical's shares. Their predictions range from $3.00 to $3.00. On average, they anticipate Aethlon Medical's share price to reach $3.00 in the next year. This suggests a possible upside of 130.8% from the stock's current price. View Analyst Price Targets for Aethlon Medical.
What is the consensus analysts' recommendation for Aethlon Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aethlon Medical.
Has Aethlon Medical been receiving favorable news coverage?
News stories about AEMD stock have trended negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aethlon Medical earned a media sentiment score of -2.5 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the next few days.
Are investors shorting Aethlon Medical?
Aethlon Medical saw a decrease in short interest during the month of December. As of December 14th, there was short interest totalling 1,239,498 shares, a decrease of 29.9% from the November 30th total of 1,767,756 shares. Based on an average trading volume of 161,715 shares, the short-interest ratio is currently 7.7 days. Currently, 7.4% of the shares of the company are sold short. View Aethlon Medical's Current Options Chain.
Who are some of Aethlon Medical's key competitors?
Who are Aethlon Medical's key executives?
Aethlon Medical's management team includes the folowing people:
- Mr. James B. Frakes, CFO & Sr. VP of Fin. (Age 61)
- Mr. James A. Joyce, Consultant & Director (Age 56)
- Dr. Timothy C. Rodell, Interim Chief Exec. Officer (Age 67)
- Dr. Annette Marleau, Director of Research (Age 43)
- Mr. Sunil Sawhney, Head of Clinical Studies
How do I buy shares of Aethlon Medical?
Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aethlon Medical's stock price today?
One share of AEMD stock can currently be purchased for approximately $1.30.
How big of a company is Aethlon Medical?
Aethlon Medical has a market capitalization of $24.28 million and generates $150,000.00 in revenue each year. The medical equipment provider earns $-5,670,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis. Aethlon Medical employs 6 workers across the globe.
What is Aethlon Medical's official website?
How can I contact Aethlon Medical?
Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]
MarketBeat Community Rating for Aethlon Medical (NASDAQ AEMD)
MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote "Outperform" if you believe AEMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
